RxDoctor Payments Data

Muneeb Shah

Dermatology · Clinton, NCNPI 1871025106

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $366,475 of the $451,118 with a category attached, or 81.2%. Galderma Laboratories, L.p. accounts for 82.6% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $271,194 and has fallen 55.0% since, to $122,065 in 2025. Among dermatology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$451,118in general payments, 2019–2025

Across 66 payments — averaging $6835.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Galderma Laboratories, L.p.$372K
  • AbbVie$78K
  • Lilly USA, LLC$280
  • Novartis$160
  • Incyte Corporation$138
  • Regeneron Healthcare Solutions, Inc.$110
  • plus $193 from 9 others

What the payments were for

  • Consulting fees$71,79816%
  • Speaking & faculty fees$366,47581%
  • Travel & lodging$10,7212%
  • Food & beverage$2,1240%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$451,118 in reported general payments places this provider in the 95th percentile of 475 dermatology providers in North Carolina.

See all dermatology providers in North Carolina

Other dermatology in Clinton

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →